跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Heptamolybdate
首页
药物
Heptamolybdate
Experimental
Small Molecule
Heptamolybdate
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
H
42
Mo
7
O
24
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pharmaceutically acceptable inorganic and organic salts of 5-methylpyrazine-2-carboxylic acid-4-oxide
US 2005261312 A1
申请人: ISP INVESTMENTS INC
优先权: 2004
US
2 件公开
Preparation method of palladium-loaded ammonium decamolybdate catalyst material
CN 112387294 A
申请人: DANYANG HENGAN CHEMICAL SCIENCE AND TECH INSTITUTE CO LTD
优先权: 2020
CN
Composite ammonium molybdate catalyst for synthesizing copper phthalocyanine
CN 115364881 A
申请人: UNIV BEIJING CHEM TECH
优先权: 2021
CN
Preparation method and application of supported molybdenum-based catalyst
CN 117920253 A
申请人: UNIV KUNMING SCIENCE & TECHNOLOGY
优先权: 2024
CN
Multifunctional nano-enzyme composite hydrogel as well as preparation method and application thereof
CN 119792190 A
申请人: UNIV ANHUI CHINESE MEDICINE
优先权: 2025
CN
Molybdenum catalyst and preparation and application thereof
CN 121927628 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2025
CN
药物
反馈